Business ❯ Pharmaceuticals

Investment

Manufacturing Research and Development Job Creation International Business Market Expansion AstraZeneca International Operations International Relations Clinical Trials Supply Chain Biotechnology Life Sciences Private Equity Dublin Development Government Funding Global Markets International Expansion Economic Development Foreign Direct Investment Corporate Strategy Healthcare Industry Expansion Plans US Market International Competitiveness Economic Impact Corporate Decisions U.S. Operations Contract Manufacturing Healthcare Sector Multinational Companies Weight Loss Medications Trade Public Investment Capacity Expansion International Investment Production Facilities

Eli Lilly to Invest $3 Billion in China to Build Orforglipron Manufacturing

The move targets localized production of the oral GLP-1 to strengthen supply ahead of potential approvals.

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

AstraZeneca Pledges $15 Billion China Expansion Through 2030

GSK Pledges $30 Billion U.S. Investment as UK Drug-Pricing Standoff Drives Pullbacks

AstraZeneca Pauses £200m Cambridge Plan as Merck Axes £1bn London Hub

AstraZeneca Commits $50 Billion to U.S. Manufacturing and Research by 2030